Could the COVID-19 oral antiviral reclassification reshape the future of pharmacy?

The role and range of services provided by pharmacists has expanded in recent years with selected oral contraceptives, vaccinations and rapid antigen testing as some examples. With the recent addition of oral antiviral therapies, will pharmacists’ medication expertise continue to be sought and funded? Is pharmacist contribution seen as integral to the health and wellbeing of communities?

In this episode, I am talking to Professor Rhiannon Braund, the President of the Pharmaceutical Society of New Zealand, to find out what she thinks the future could hold for pharmacy.